By G HossainPosted on October 21, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Silence Therapeutics’ lead siRNA asset for the rare blood cancer polycythemia vera has been earning analyst raves in a tight race to challenge Takeda in a potential $2 billion market. Merck KGaA makes noise in hematology with $1.1B Silence buy Post navigation Roche returns to Hansoh with broad $15B ADC dealEyePoint will halve workforce, end pivotal wet AMD trials early following second fail
